Literature DB >> 9591824

Lasting immunity to varicella in doctors study (L.I.V.I.D. study).

B A Solomon1, A G Kaporis, A T Glass, S I Simon, H E Baldwin.   

Abstract

Mesh：

Year:  1998        PMID： 9591824     DOI： 10.1016/s0190-9622(98)70207-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  9 in total

Review 1.  Herpes zoster and postherpetic neuralgia: past, present and future.

Authors:  Gary J Bennett; C Peter N Watson
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

2.  Herpes zoster vaccine for the elderly: boosting immunity.

Authors:  Joel V Chua; Wilbur H Chen
Journal:  Aging health       Date:  2010-04-01

3.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

4.  Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination.

Authors:  James G Donahue; Burney A Kieke; Paul M Gargiullo; Aisha O Jumaan; Nicholas R Berger; Jeremy S McCauley; Edward A Belongia
Journal:  Am J Public Health       Date:  2010-01-14       Impact factor: 9.308

Review 5.  Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review.

Authors:  Benson Ogunjimi; Pierre Van Damme; Philippe Beutels
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 6.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

7.  Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia.

Authors:  Kevin J Friesen; Dan Chateau; Jamie Falk; Silvia Alessi-Severini; Shawn Bugden
Journal:  BMC Infect Dis       Date:  2017-01-13       Impact factor: 3.090

8.  Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.

Authors:  Z Gao; J G Wood; H F Gidding; A T Newall; R I Menzies; H Wang; P B McIntyre; C R MacIntyre
Journal:  Epidemiol Infect       Date:  2014-09-15       Impact factor: 4.434

9.  Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Hum Exp Toxicol       Date:  2013-11-25       Impact factor: 2.903
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.